Aurobindo Pharma
- Aurobindo Pharma has received final approval from the United States Food & Drug Administration (USFDA) to manufacture Sevelamer Carbonate oral suspension, 0.8 gm and 2.4 gm,” as per company release.
- The Sevelamer Carbonate oral suspension is a therapeutic equivalent generic version of Genzyme’s Renvela oral suspension.
- The product is being launched immediately.
- Alkem Labs gets US FDA nod for fungal infection drug, Itraconazole Capsule
- Wockhardt gets tentative US FDA nod for Bendamustine Hydrochloride injectable (used to treat different types of cancer)
No comments:
Post a Comment